Pancrealipase DR for Exocrine Pancreatic Insufficieny (EPI)
May 30, 2012 by
Posted in CANCER BIOLOGY & Innovations in Cancer Therapy, Health Economics and Outcomes Research, International Global Work in Pharmaceutical, Personalized and Precision Medicine & Genomic Research, Pharmaceutical Industry Competitive Intelligence, Population Health Management, Genetics & Pharmaceutical | Tagged Cancer - General, Cystic fibrosis, EPI, Exocrine pancreatic insufficiency, Food and Drug Administration, health, Pancreatic cancer | Leave a Comment
Leave a Reply